SPOTLIGHT -
Match your needs to your customers'
Try the 'match and move' method.
Do you offer value to critical customers?
Improving your quality outcome.
Company helps rep cultivate skills
Medeva set up its management development program for people like Jim Brosius, an eight-year pharmaceutical sales veteran who is doing fantastic work in his position educating hospital fellows and residents.
Using the Internet as a tool for Rx sales
Using the Internet to answer health questions.
'Inappropriate' gift-giving raises concerns at AMA
A letter from the American Medical Association
FDA: User fee monies drop
Prescription drug user fee revenues will be $59 million lower than originally expected over the five years of the Prescription Drug User Fee Act II, the Food and Drug Administration announced.
How reps sell around the globe
'Snapshots' of selling environments from other parts of the world.
Forum brings diverse group together
Novartis became the fifth pharmaceutical company to join the Academic Medicine and Managed Care Forum.
Reform issue heats up
Reps. John Shadegg (R-AZ) and Tom Coburn (R-OK) added their Health Care Quality and Choice Act to the growing list of managed care bills being considered by Congress.
Pfizer meets LTC needs
Long-term care executives named Pfizer Inc., New York, the pharmaceutical company that best meets their needs.
Rx errors frighten patients
The potential for medication mix-ups worries patients most, followed by fear of negative drug interactions and treatment costs.
Study reveals drug volume, prices on the rise
Total retail prescription drug sales for 1999 are expected to exceed $121.6 billion.
Drug pricing bill introduced
Rep. Sherrod Brown (D-OH) introduced a bill that would use market competition to reduce the cost of prescription drugs.
Do you know your doctor's style?
Profiling the physicians you sell to.
Medicare drug coverage varies by HMO
Drug benefits for enrollees in Medicare health maintenance organizations vary greatly from plan to plan.
Flonase ads failed to disclose risk
The Food and Drug Administration claims that Glaxo Wellcome's Spanish-language television advertisements for Flonase® (fluticasone) nasal spray, which ran in Puerto Rico in 1998 and 1999, failed to disclose risk information.
For-profits cost Medicare more
For-profit hospitals cost the Medicare program more than not-for-profit hospitals, according to a recent article published in the New England Journal of Medicine (vol. 341, no. 6).
Advertising: the cause of high drug costs?
The National Institute for Health Care Management has released a report that cites DTC advertising as a major force behind rising prescription drug expenditures.
Organizations tackle compliance issue
The American Heart Association has estimated that patient non-compliance with physician instructions regarding medication use costs the United States $100 billion annually in unnecessary medical costs and lost national productivity.
Try the Socratic approach
Classic tips for earning a customer's trust.
WLF/FDAMA ruling upheld
FDA regulations violate free speech
You talk, talk, talk–but do you listen?
Active listening will help you remain focused on your customers, thereby allowing you to uncover their real needs.
Breaking through the access barrier
Pharmaceutical sales representatives claim that up to 45% of the physicians in their territories are difficult – if not impossible – to see. Here's how to get inside the no-see offices.
Johnson & Johnson, Centocor to merge
Johnson & Johnson, New Brunswick, NJ, has entered into an agreement with Centocor Inc., Malvern, PA, under which the two companies will merge.
AIDS: birth transmission falls
Transmission of AIDS from mothers to their infants fell 67% between 1992 and 1997, according to an article in the Journal of the American Medical Association.
Sales reps make time for their communities
PR salutes reps who make a difference.
Industry lobbies for patent extensions
Congress is considering a bill that would establish an independent review process to consider patent extensions for drugs that spent more time than normal in the FDA review process.
New board members
Pharmaceutical Representative welcomed two new members to its editorial advisory board in 1999: Mark Osborne, director of sales training at Chicago-based Searle and Professor Mickey Smith, professor of pharmacy administration and the director of the Center for Pharmaceutical Marketing and Management at the University of Mississippi.
Legal expert explains WLF decision
On July 28, a district court judge in Washington ruled that some provisions of the FDA Modernization Act are unconstitutional because they violate pharmaceutical companies' rights to free speech.
Formulary is evidence-based
An "evidence-based formulary" that compares the safety, efficacy and cost of pharmaceuticals in the top eight therapeutic classes is being made available to clients of Express Scripts.